Global Animal Vaccines by Product Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type [Companion animals (Dogs, Cats, and Others), Cattle, Pigs, Poultry, and Sheep] - Global Opportunity Analysis and Industry Forecast, 2014-2022
- ALL1051152
- 160 Pages
- March 2017
- Pharmaceuticals
Veterinary vaccines are used for prevention of diseases that affect animals. Animal vaccination is a cost-effective solution to maintain animal health and sustainability, offering various benefits such as improved animal health & welfare of companion animals, improvement in livestock products, and prevention of transmission of diseases from animal to humans. Humans are largely dependent on animals, as they are the major source of milk, meat, and other dairy products. Thus, with increase in population, the demand for animal products also increases, fueling the production of vaccines for cattle, pigs, poultry, and sheep.
The growth of animal vaccines market is driven by increase in healthcare spending by governments. In addition, rise in consumption of meat, milk, and protein; and extensively growing pet ownership drive the market. However, lack of awareness toward pet health and expensive storage & production of vaccines are expected to restrain the growth of the market.
KEY BENEFITS
- The global animal vaccines market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
- The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.
- The market scenario is comprehensively analyzed with respect to the product type and animal type.
- Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
- In-depth geographical analysis helps to understand the regional market, which assists in strategic business planning.
KEY MARKET SEGMENTS
By Product
- Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Conjugate Vaccines
- Recombinant Vaccines
- DNA Vaccines
By Animal Type
- Companion Animals
- Dogs
- Cats
- Others
- Cattle
- Pigs
- Poultry
- Sheep
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- Rest of LAMEA
The key players profiled in this report include the following:
- Bayer AG
- Eli Lilly and Company
- Boehringer
- Ingelheim GmbH
- Merck & Co., Inc.
- Zoetis Inc.
- Ceva Santé Animale
- Sanofi S.A.
- Nutreco N.V.
- Virbac S.A.
The other players of the animal therapeutics and diagnostics market include (companies not profiled in the report):
- Nexvet
- PHL Associates, Inc.
- Hygieia Biological Laboratories
- Colorado Serum Company
- Pfizer
- Arko Laboratories, Ltd.
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.3. GOVERNMENT REGULATIONS
3.3.1. Center for Veterinary Biologics(CVB)
3.4. PATENTS ANALYSIS
3.4.1. PATENT ANALYSIS BY YEAR
3.4.2. PATENT ANALYSIS BY REGION
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Rising demand for animal derived food products
3.5.1.2. Growing demand for pet insurance
3.5.1.3. Rising concern to prevent zoonotic diseases
3.5.1.4. Growing ownership of companion animals
3.5.1.5. Rising animal health expenditure
3.5.2. Restraints
3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Lack of animal health awareness
3.5.2.3. Adverse impact of veterinary vaccines on human and animal health
3.5.3. Opportunities
3.5.3.1. Advancement in vaccine products
3.5.3.2. Vaccine products for hybrid animals
CHAPTER 4 ANIMAL VACCINES MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ATTENUATED VACCINES
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. INACTIVATED VACCINES
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. SUBUNIT VACCINES
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. TOXOID VACCINES
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.6. CONJUGATE VACCINES
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.7. RECOMBINANT VACCINES
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.8. DNA VACCINES
4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast
CHAPTER 5 ANIMAL VACCINES MARKET, BY ANIMAL TYPE
5.1. OVERVIEW
5.2. COMPANION ANIMALS
5.2.1. Market size and forecast
5.2.2. Dogs
5.2.3. Cats
5.2.4. Other Companion Animals
5.3. CATTLE
5.3.1. Market size and forecast
5.4. PIGS
5.4.1. Market size and forecast
5.5. POULTRY
5.5.1. Market size and forecast
5.6. SHEEP
5.6.1. Market size and forecast
CHAPTER 6 ANIMAL VACCINES MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size & forecast
6.2.5. Canada market size & forecast
6.2.6. Mexico market size & forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size & forecast
6.3.5. France market size & forecast
6.3.6. UK market size & forecast
6.3.7. Italy market size & forecast
6.3.8. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size & forecast
6.4.5. China market size & forecast
6.4.6. Australia market size & forecast
6.4.7. India market size & forecast
6.4.8. South Korea market size & forecast
6.4.9. Taiwan market size & forecast
6.4.10. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size & forecast
6.5.5. Turkey market size & forecast
6.5.6. Venezuela market size & forecast
6.5.7. Saudi Arabia market size & forecast
6.5.8. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. MERCK & CO., INC.
7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves & developments
7.2. ZOETIS INC.
7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments
7.3. CEVA SANT ANIMALE
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance
7.4. SANOFI S.A.
7.4.1. Company overview
7.4.2. Business performance
7.4.3. Key strategic moves & developments
7.5. ROMVAC
7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance
7.6. VAXXINOVA
7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.7. BIOVAC
7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments
7.8. MERIAL
7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance
7.9. ANICON LABOR GMBH
7.9.1. Company overview
7.9.2. Business performance
7.9.3. Key strategic moves & developments
LIST OF TABLES
TABLE 1. GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT TYPE ($MILLION)
TABLE 2. GLOBAL ATTENUATED ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 3. GLOBAL INACTIVATED ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 4. GLOBAL SUBUNIT ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 5. GLOBAL TOXOID ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 6. GLOBAL CONJUGATE ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 7. GLOBAL RECOMBINANT ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 8. GLOBAL DNA ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 9. GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 10. GLOBAL COMPANION ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 11. GLOBAL ANIMAL VACCINES CATTLE MARKET, BY GEOGRAPHY ($MILLION)
TABLE 12. GLOBAL ANIMAL VACCINES PIGS MARKET, BY GEOGRAPHY ($MILLION)
TABLE 13. GLOBAL ANIMAL VACCINES POULTRY MARKET, BY GEOGRAPHY ($MILLION)
TABLE 14. GLOBAL ANIMAL VACCINES SHEEP MARKET, BY GEOGRAPHY ($MILLION)
TABLE 15. GLOBAL ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 16. NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 17. NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 18. NORTH AMERICA COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 20. EUROPE VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 21. EUROPE VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 22. EUROPE COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 23. EUROPE ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 24. ASIA-PACIFIC VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 25. ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 26. ASIA-PACIFIC COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 27. ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 28. LAMEA VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 29. LAMEA VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 30. LAMEA COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 31. LAMEA ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 32. ROMVAC: COMPANY SNAPSHOT
TABLE 33. ROMVAC: OPERATING SEGMENTS
TABLE 34. VAXXINOVA: COMPANY SNAPSHOT
TABLE 35. VAXXINOVA: OPERATING SEGMENTS
TABLE 36. BIOVAC: COMPANY SNAPSHOT
TABLE 37. BIOVAC: OPERATING SEGMENTS
TABLE 38. MERCK: COMPANY SNAPSHOT
TABLE 39. MERCK: OPERATING SEGMENTS
TABLE 40. ZOETIS: COMPANY SNAPSHOT
TABLE 41. ZOETIS: OPERATING SEGMENTS
TABLE 42. CEVA SANT ANIMALE: COMPANY SNAPSHOT
TABLE 43. CEVA SANT ANIMALE: OPERATING SEGMENTS
TABLE 44. SANOFI: COMPANY SNAPSHOT
TABLE 45. SANOFI: OPERATING SEGMENTS
TABLE 46. MERIAL: COMPANY SNAPSHOT
TABLE 47. MERIAL: OPERATING SEGMENTS
TABLE 48. ANICON LABOR GMBH: COMPANY SNAPSHOT
TABLE 49. ANICON LABOR GMBH: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ANIMAL VACCINES MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE
FIGURE 3. U.S. ANIMAL VACCINES MARKET, 2014-2022
FIGURE 4. CANADA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 5. MEXICO ANIMAL VACCINES MARKET, 2014-2022
FIGURE 6. GERMANY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 7. FRANCE ANIMAL VACCINES MARKET, 2014-2022
FIGURE 8. UK ANIMAL VACCINES MARKET, 2014-2022
FIGURE 9. ITALY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 10. REST OF EUROPE ANIMAL VACCINES MARKET, 2014-2022
FIGURE 11. JAPAN ANIMAL VACCINES MARKET, 2014-2022
FIGURE 12. CHINA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 13. AUSTRALIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 14. INDIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 15. SOUTH KOREA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 16. TAIWAN ANIMAL VACCINES MARKET, 2014-2022
FIGURE 17. REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, 2014-2022
FIGURE 18. BRAZIL ANIMAL VACCINES MARKET, 2014-2022
FIGURE 19. TURKEY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 20. VENEZEULA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 21. SAUDI ARABIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 22. LAMEA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 23. ROMVAC: REVENUE, BY YEAR ($MILLION)
FIGURE 24. ROMVAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 25. ROMVAC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 26. VAXXINOVA: REVENUE, BY YEAR ($MILLION)
FIGURE 27. VAXXINOVA: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 28. VAXXINOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 29. BIOVAC: REVENUE, BY YEAR ($MILLION)
FIGURE 30. BIOVAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 31. BIOVAC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 32. MERCK: REVENUE, BY YEAR ($MILLION)
FIGURE 33. MERCK: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 34. MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 35. ZOETIS: REVENUE, BY YEAR ($MILLION)
FIGURE 36. ZOETIS: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 37. ZOETIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 38. CEVA SANT ANIMALE: REVENUE, BY YEAR ($MILLION)
FIGURE 39. CEVA SANT ANIMALE: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 40. CEVA SANT ANIMALE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 41. SANOFI: REVENUE, BY YEAR ($MILLION)
FIGURE 42. SANOFI: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 43. SANOFI: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 44. MERIAL: REVENUE, BY YEAR ($MILLION)
FIGURE 45. MERIAL: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 46. MERIAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 47. ANICON LABOR GMBH: REVENUE, BY YEAR ($MILLION)
FIGURE 48. ANICON LABOR GMBH: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 49. ANICON LABOR GMBH: REVENUE, BY GEOGRAPHY, 2015 (%)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
